In conclusion, we show that miltirone inhibits the proliferation of GC cells and significantly potentiates the anticancer activities of cisplatin both in vivo and in vitro by downregulating the PI3K/Akt signaling pathway (Figure 9). This evidence concerns the gene AKT1 and gastric cancer.